Randomized Comparison of the Abbott WHITESTAR Signature System With Ellips Tranversal Ultrasound vs. the Alcon Infiniti With the Ozil Torsional Handpiece in Phacoemulsification: A Contralaterally-Controlled Trial

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-10-31

Study Completion Date

2012-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to look at the outcomes of your vision after your cataract surgery based on two different types of equipment that will be used during your surgery.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of the Femtosecond Laser System as Compared to Continuous Curvilinear Capsulorhexis for Cataract Surgery

NCT01069172

Cataract

COMPLETED PHASE3

Femtosecond Laser for Cataract Surgery

NCT02110212

Cataract

TERMINATED PHASE3

Clinical Evaluation of the One-Piece Tecnis Multifocal Intraocular Lens (IOL)

NCT01210807

Cataract

COMPLETED PHASE4

Intra-Operative Metrics With CENTURION® and INFINITI® Vision Systems

NCT01848288

Cataract

COMPLETED NA

Cataract Refractive Suite Study

NCT02974140

Cataracts

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cataracts Astigmatism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Abbott WHITESTAR Signature System

Abbott WHITESTAR Signature System with Ellips Transversal Ultrasound

Group Type EXPERIMENTAL

Abbott WHITESTAR Signature System with Ellips Transversal Ultrasound

Intervention Type DEVICE

Comparison of vision after cataract surgery based on two different types of equipment.

Alcon Infiniti

Alcon Infiniti with the OZIL Torsional Handpiece

Group Type EXPERIMENTAL

Alcon Infiniti wiht the OZIL Torsional Handpiece

Intervention Type DEVICE

Comparision of vision after cataract surgery based on two different types of equipment.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Abbott WHITESTAR Signature System with Ellips Transversal Ultrasound

Comparison of vision after cataract surgery based on two different types of equipment.

Intervention Type DEVICE

Alcon Infiniti wiht the OZIL Torsional Handpiece

Comparision of vision after cataract surgery based on two different types of equipment.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients at least 21 scheduled to undergo bilateral phacoemulsification with implantation of multifocal IOLs.
* Both eyes must have similar degrees of cataract and astigmatism (topographic cylinder difference of \<2.00D as well as similar globe axial length as measured by the IOL Master of \<0.5mm).
* Visual potential of UCVA 20/25/ or better.
* Clear intraocular media other than cataract.

Exclusion Criteria

* Clinically relevant differences between eyes in ocular disease or pathology.
* Presence of glaucoma, macular disease, or foveal disease to an asymmetrical degree.
* Asymmetrical use of ocular medications.

Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No